1 – 10 of 1583
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.
(
- Contribution to journal › Article
-
Mark
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure - two nationwide, population-based cohort studies
(
- Contribution to journal › Article
-
Mark
Size distribution of exhaled aerosol particles containing SARS-CoV-2 RNA
(
- Contribution to journal › Article
-
Mark
The prevalence of adverse reactions among individuals with three-dose COVID-19 vaccination
(
- Contribution to journal › Article
-
Mark
Transmission factors and exposure to infections at work and invasive pneumococcal disease
(
- Contribution to journal › Article
-
Mark
Autoantibodies against red blood cell antigens are common in a Malaria endemic area
(
- Contribution to journal › Article
-
Mark
Virologic failure following low-level viremia and viral blips during antiretroviral therapy: results from a European multicenter cohort
2023) In Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 76(1).(
- Contribution to journal › Article
-
Mark
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
(
- Contribution to journal › Letter
-
Mark
Rapid emergence of omicron sublineages expressing spike protein R346T
(
- Contribution to journal › Letter
-
Mark
Influenza vaccine effectiveness in patients hospitalized with severe acute respiratory infection in Lithuania during the 2019-2020 influenza season : a test negative case - control study
(
- Contribution to journal › Article